Loading…
for educational and safety purposes
Andarine and Ostarine both come up in the same conversations; they overlap on Androgen Receptor. Andarine: Andarine (S-4) is a non-steroidal selective androgen receptor modulator derived from arylpropionamide chemistry that binds the androgen receptor with high affinity yet acts in a tissue-selective manner. Ostarine: Ostarine, known in drug development as enobosarm or MK-2866, is an investigational selective androgen receptor modulator (SARM).
Andarine (S-4) is a non-steroidal selective androgen receptor modulator derived from arylpropionamide chemistry that binds the androgen receptor with high affinity yet acts in a tissue-selective manner. In castrated and ovariectomized rodents it restored skeletal muscle mass and strength, raised bone mineral density, and reduced body fat while stimulating the prostate and seminal vesicles far less than dihydrotestosterone; this partial-agonist behavior in androgenic organs versus full-agonist activity in muscle and bone defines the SARM concept. Its favorable pharmacokinetics, including high oral bioavailability and predominantly hepatic phase I and II metabolism, once positioned it as a clinical candidate for muscle wasting and osteoporosis. It was never approved for human use, however, and is prohibited in sport, so it is documented largely through preclinical pharmacology and anti-doping detection studies rather than clinical trials.
Ostarine, known in drug development as enobosarm or MK-2866, is an investigational selective androgen receptor modulator (SARM). SARMs are compounds designed to stimulate the androgen receptor in a tissue-selective way, aiming to build muscle and bone like anabolic steroids but with fewer effects on organs such as the prostate. Ostarine has been studied mainly for the muscle wasting associated with cancer and related conditions, but it is not approved as a medicine anywhere; it is prohibited in sport and has been the subject of regulatory warnings over its sale in bodybuilding and supplement products.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
Selective partial agonist
Agonist (tissue-selective)
DHT antagonism
Anabolic stimulation
Suppresses
Lowers
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.